CIK 0001680581
- Non-accelerated filer
- Smaller reporting company
Fulcrum Therapeutics, Inc.
Sign in to watch- Ticker
- FULC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474839948
- Phone
- +1 617-651-8851
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-05 | Gould Robert J | Sale | −3,433 | $20.17 | $69K | 540,001 |
| 2020-06-05 | Cadavid Diego SVP Clinical Development | Exercise or conversion | +451 | $4.83 | $2K | 67,236 |
| 2020-06-05 | Cadavid Diego SVP Clinical Development | Sale | −451 | $20.18 | $9K | 66,785 |
| 2020-06-05 | Cadavid Diego SVP Clinical Development | Exercise or conversion · Stock Option (right to buy) | −451 | 14,137 | ||
| 2020-06-04 | Cadavid Diego SVP Clinical Development | Exercise or conversion | +226 | $4.83 | $1K | 67,011 |
| 2020-06-04 | Cadavid Diego SVP Clinical Development | Sale | −226 | $20.05 | $5K | 66,785 |
| 2020-06-04 | Cadavid Diego SVP Clinical Development | Exercise or conversion · Stock Option (right to buy) | −226 | 14,588 | ||
| 2020-06-04 | Gould Robert J | Sale | −1,300 | $20.04 | $26K | 543,434 |
| 2020-06-03 | Gould Robert J | Sale | −1,500 | $20.13 | $30K | 544,734 |
| 2020-06-03 | Cadavid Diego SVP Clinical Development | Exercise or conversion | +338 | $4.83 | $2K | 67,123 |
| 2020-06-03 | Cadavid Diego SVP Clinical Development | Sale | −338 | $20.18 | $7K | 66,785 |
| 2020-06-03 | Cadavid Diego SVP Clinical Development | Exercise or conversion · Stock Option (right to buy) | −338 | 14,814 | ||
| 2020-06-02 | Cadavid Diego SVP Clinical Development | Exercise or conversion | +45 | $4.83 | $217 | 66,830 |
| 2020-06-02 | Cadavid Diego SVP Clinical Development | Sale | −45 | $20.00 | $900 | 66,785 |
| 2020-06-02 | Cadavid Diego SVP Clinical Development | Exercise or conversion · Stock Option (right to buy) | −45 | 15,152 | ||
| 2020-06-02 | Gould Robert J | Sale | −2,797 | $20.00 | $56K | 546,234 |
| 2020-06-01 | Gould Robert J | Sale | −5 | $20.00 | $100 | 549,031 |
| 2020-05-29 | Cadavid Diego SVP Clinical Development | Exercise or conversion | +200 | $4.83 | $966 | 66,985 |
| 2020-05-29 | Cadavid Diego SVP Clinical Development | Sale | −200 | $20.04 | $4K | 66,785 |
| 2020-05-29 | Cadavid Diego SVP Clinical Development | Exercise or conversion · Stock Option (right to buy) | −200 | 15,197 |
Page 11 of 15 · 291 trades